The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115392768 11539276 8 F 201502 20160817 20150923 20160826 EXP US-PFIZER INC-2015302339 PFIZER 71.00 YR M Y 0.00000 20160826 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115392768 11539276 1 PS SUTENT SUNITINIB MALATE 1 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) Y B422BA 21938 50 MG CAPSULE, HARD
115392768 11539276 2 SS SUTENT SUNITINIB MALATE 1 37.5 MG, DAILY Y 21938 37.5 MG CAPSULE, HARD
115392768 11539276 3 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 UNK 0
115392768 11539276 4 C VITAMIN B12 CYANOCOBALAMIN 1 1000 UG, MONTHLY 0 1000 UG /month
115392768 11539276 5 C DUTASTERIDE. DUTASTERIDE 1 UNK 0
115392768 11539276 6 C BENICAR OLMESARTAN MEDOXOMIL 1 UNK (40) 0
115392768 11539276 7 C BENICAR OLMESARTAN MEDOXOMIL 1 UNK (20) 0
115392768 11539276 8 C AMLODIPINE AMLODIPINE BESYLATE 1 UNK 0
115392768 11539276 9 C OMEPRAZOLE. OMEPRAZOLE 1 20 MG, DAILY 0 20 MG
115392768 11539276 10 C CHLORHEXIDINE GLUCONATE. CHLORHEXIDINE GLUCONATE 1 0.12 %, UNK 0 .12 PCT
115392768 11539276 11 C ZINC OXIDE. ZINC OXIDE 1 Rectal UNK 0 CREAM
115392768 11539276 12 C CLOTRIMAZOLE. CLOTRIMAZOLE 1 Topical UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115392768 11539276 1 Metastatic renal cell carcinoma
115392768 11539276 5 Prostatomegaly
115392768 11539276 6 Hypertension
115392768 11539276 8 Hypertension
115392768 11539276 10 Mouth ulceration

Outcome of event

Event ID CASEID OUTC COD
115392768 11539276 HO
115392768 11539276 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
115392768 11539276 Abdominal distension
115392768 11539276 Asthenia
115392768 11539276 Blood pressure decreased
115392768 11539276 Blood urine present
115392768 11539276 Decreased appetite
115392768 11539276 Dehydration
115392768 11539276 Diarrhoea
115392768 11539276 Dry eye
115392768 11539276 Dry mouth
115392768 11539276 Dry skin
115392768 11539276 Dysgeusia
115392768 11539276 Dyspepsia
115392768 11539276 Epistaxis
115392768 11539276 Fatigue
115392768 11539276 Gastrooesophageal reflux disease
115392768 11539276 Haemoglobin decreased
115392768 11539276 Haemorrhage
115392768 11539276 Hair texture abnormal
115392768 11539276 Hypertension
115392768 11539276 Hypothyroidism
115392768 11539276 Oral discomfort
115392768 11539276 Oral pain
115392768 11539276 Oropharyngeal plaque
115392768 11539276 Platelet count abnormal
115392768 11539276 Pruritus
115392768 11539276 Rash
115392768 11539276 Sunburn
115392768 11539276 Syncope
115392768 11539276 Temperature intolerance
115392768 11539276 Thrombocytopenia
115392768 11539276 Vitamin B12 decreased
115392768 11539276 Weight decreased
115392768 11539276 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115392768 11539276 1 20150120 0
115392768 11539276 3 20150512 0
115392768 11539276 4 20150727 0